Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company TheVax Genetics Vaccine Co. Ltd.
DescriptionPEK fusion protein
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic
Latest Stage of DevelopmentPhase II
Standard IndicationHuman papillomavirus (HPV)
Indication DetailsTreat high-grade squamous intraepithelial lesions (HSIL) associated with human papillomavirus (HPV) infection
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today